Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global peripheral vascular devices market size is likely to be valued at US$ 5.9 Bn in 2025 and is estimated to reach US$ 9.5 Bn by 2032, growing at a CAGR of 7.04% during the forecast period from 2025 to 2032. The market is experiencing steady growth due to the rising prevalence of peripheral artery disease, growing demand for minimally invasive procedures, and technological advancements in vascular intervention. Increasing geriatric population and associated vascular disorders are further driving the adoption of peripheral vascular devices across healthcare facilities worldwide.



Peripheral Vascular Devices Market - Report Scope:

The peripheral vascular devices market includes a broad spectrum of medical devices used to treat conditions affecting blood vessels outside of the heart and brain. These include stents, catheters, balloons, and scaffolds used in endovascular procedures to restore proper blood flow. With growing global burden of lifestyle-related conditions like diabetes and obesity, demand for effective vascular solutions has intensified. The market is also being shaped by ongoing innovation in bioresorbable scaffolds, drug-eluting technologies, and image-guided catheterization tools.



Key Market Drivers:

One of the primary drivers of the peripheral vascular devices market is the increasing incidence of peripheral artery disease (PAD) globally. Aging populations, sedentary lifestyles, and rising rates of smoking and diabetes are contributing to vascular health deterioration. Advancements in device technologies, including drug-coated balloons and bioresorbable vascular scaffolds, are enhancing clinical outcomes and boosting adoption. In addition, increasing preference for minimally invasive endovascular procedures over traditional surgery is propelling market demand. Government initiatives and healthcare spending aimed at improving vascular health are further supporting market expansion.



Market Restraints:

Despite significant growth potential, the peripheral vascular devices market faces challenges such as high treatment costs and limited access in low- and middle-income regions. Reimbursement complexities in some countries can hinder the adoption of advanced vascular devices. Additionally, the risk of restenosis, device failure, and procedure-related complications continues to raise concerns among both patients and physicians. Regulatory hurdles for new product approvals and pricing pressures from healthcare systems may also slow down market penetration.



Emerging Business Opportunities:

The market offers notable opportunities for manufacturers focusing on next-generation vascular devices that deliver enhanced safety and efficacy. Growth in emerging economies such as India, China, Brazil, and Southeast Asia, driven by increasing healthcare infrastructure and awareness, presents a lucrative expansion landscape. Collaborations with healthcare providers and investments in clinical trials can help validate device performance and accelerate market entry. The increasing role of AI and advanced imaging in vascular interventions also offers potential for differentiation and innovation in procedural precision.



Regional Outlook:

North America holds a dominant share in the global peripheral vascular devices market, supported by a well-established healthcare infrastructure, high prevalence of PAD, and early adoption of advanced vascular technologies. Europe follows closely, with countries like Germany, France, and the UK showing strong demand for minimally invasive vascular procedures. The Asia Pacific region is expected to witness the fastest growth due to increasing chronic disease burden, aging population, and expanding access to interventional care. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as promising markets with rising investments in healthcare modernization.



Leading Companies:

Leading companies in the global peripheral vascular devices market, such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic Plc, are actively engaged in product development, clinical innovation, and strategic acquisitions to strengthen their market position. Firms are focusing on creating flexible, deliverable, and drug-eluting platforms that reduce restenosis risk and improve long-term patient outcomes. Collaborations with hospitals and catheterization labs, along with robust after-sales support, are key elements of their expansion strategies.



Companies Covered in This Report:
• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical Inc.
• MicroPort Scientific Corporation (Endovastec™)
• Medtronic Plc.
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Becton, Dickinson, and Company
• W. L. Gore & Associates Inc.
• Getinge AB
• Terumo Corp
• Kyoto Medical Planning Co Ltd
• iVascular S.L.U
• AMG International GmbH
• ENDOCOR GmbH
• Meril Life Sciences Pvt. Ltd.
• Nano Therapeutics Pvt Ltd
• Koninklijke Philips N.V.
• REVA Medical



Market Segmentation:

By Product:
• Peripheral Vascular Stents
Self-Expanding Stents
Balloon Expanding Stents
Covered Stents
Drug Eluting Stents
• Drug Eluting Balloons
• Peripheral Vascular Bioresorbable Scaffolds

By Indication:
• Target Artery Instability (TAI)
• Access Artery Injury (AAI)
• Peripheral Arterial Disease
• Arteriovenous Fistulas
• Peripheral Aneurysms
• Others

By Artery Type:
• Carotid Artery
• Fem-Pop Artery
• Iliac Artery
• Infrapop Artery

By End User:
• Hospitals
• Ambulatory Surgical Centers/Outpatients
• Cardiac Catheterization Labs

By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: Delivery Timelines - 5 working days. Show more